OTC:CERO | Free Cash Flow | CERO THERAPEUTICS HOLDINGS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-09-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$2.8M
2023-12-31-$186,609.00
2023-03-31-$197,777.00
2022-12-31-$373,100.00
2022-03-31-$308,091.00
2021-09-30$0.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$16.1M
2023-12-31-$1.52M
2022-12-31-$1.09M